UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma

Cancer research (Chicago, Ill.), 2018-06, Vol.78 (11), p.2886-2896

2018

Volltextzugriff (PDF)

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

Clinical cancer research, 2018-12, Vol.24 (23), p.5977-5989

2018

Volltextzugriff (PDF)

An Ultrasonically Powered Implantable Micro-Oxygen Generator (IMOG)

IEEE transactions on biomedical engineering, 2011-11, Vol.58 (11), p.3104-3111

2011

Volltextzugriff (PDF)

Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures

Bone (New York, N.Y.), 2003-10, Vol.33 (4), p.652-659

2003

Volltextzugriff (PDF)

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status

Cancer, 2004-07, Vol.101 (1), p.83-89

2004

Volltextzugriff (PDF)

High-Level Expression of EphA2 Receptor Tyrosine Kinase in Prostatic Intraepithelial Neoplasia

The American journal of pathology, 2003-12, Vol.163 (6), p.2271-2276

2003

Volltextzugriff (PDF)

Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models

Urologic oncology, 2011-11, Vol.29 (6), p.802-808

2011

Volltextzugriff (PDF)

Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy

Clinical cancer research, 2008-01, Vol.14 (1), p.291-299

2008

Volltextzugriff (PDF)

Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

International journal of cancer, 1998-09, Vol.77 (6), p.887-894

1998

Volltextzugriff (PDF)

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer

Human gene therapy, 2003-02, Vol.14 (3), p.227-241

2003

Volltextzugriff (PDF)

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1941-1951

2005

Volltextzugriff (PDF)

Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells

The Journal of biological chemistry, 2002-01, Vol.277 (4), p.2468-2476

2002

Volltextzugriff (PDF)

Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy

Clinical cancer research, 2007-09, Vol.13 (18), p.5463-5473

2007

Volltextzugriff (PDF)

Androgen Withdrawal Inhibits Tumor Growth and Is Associated with Decrease in Angiogenesis and VEGF Expression in Androgen-Independent CWR22Rv1 Human Prostate Cancer Model

Anticancer research, 2004-07, Vol.24 (4), p.2135-2140

2004

Volltextzugriff (PDF)

Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

The journal of gene medicine, 2010-06, Vol.12 (6), p.516-527

2010

Volltextzugriff (PDF)

Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy

Clinical cancer research, 2018-12, Vol.24 (24), p.6383-6395

2018

Volltextzugriff (PDF)

Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers

Molecular therapy, 2002-09, Vol.6 (3), p.415-421

2002

Volltextzugriff (PDF)

Androgen-Repressed Phenotype in Human Prostate Cancer

Proceedings of the National Academy of Sciences - PNAS, 1996-12, Vol.93 (26), p.15152-15157

1996

Volltextzugriff (PDF)

Regions of Prostate-specific Antigen (PSA) Promoter Confer Androgen-independent Expression of PSA in Prostate Cancer Cells

The Journal of biological chemistry, 2000-12, Vol.275 (52), p.40846-40855

2000

Volltextzugriff (PDF)

A novel targeting modality to enhance adenoviral replication by vitamin D3 in androgen-independent human prostate cancer cells and tumors

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (11), p.3084-3092

2002

Volltextzugriff (PDF)

Abstract 3109: Investigating the role of wild-type TFE3 in renal cell carcinoma cells harboring TFE3 fusions with spliceosome machinery associated genes

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3109-3109

2018

Volltextzugriff (PDF)

Tip110, the Human Immunodeficiency Virus Type 1 (HIV-1) Tat-interacting Protein of 110 kDa as a Negative Regulator of Androgen Receptor (AR) Transcriptional Activation

The Journal of biological chemistry, 2004-05, Vol.279 (21), p.21766-21773

2004

Volltextzugriff (PDF)

DEVELOPMENT OF PROSTATE-SPECIFIC ANTIGEN PROMOTER-BASED GENE THERAPY FOR ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER

The Journal of urology, 1998-07, Vol.160 (1), p.220-229

1998

Volltextzugriff (PDF)

The role of interleukin‐12 on modulating myeloid‐derived suppressor cells, increasing overall survival and reducing metastasis

Immunology, 2011-06, Vol.133 (2), p.221-238

2011

Volltextzugriff (PDF)

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene

Molecular cancer therapeutics, 2006-03, Vol.5 (3), p.676-684

2006

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(121)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

An Ultrasonically Powered Implantable Micro-Oxygen Generator (IMOG)

Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status

High-Level Expression of EphA2 Receptor Tyrosine Kinase in Prostatic Intraepithelial Neoplasia

Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models

Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy

Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer

Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells

Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy

Androgen Withdrawal Inhibits Tumor Growth and Is Associated with Decrease in Angiogenesis and VEGF Expression in Androgen-Independent CWR22Rv1 Human Prostate Cancer Model

Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy

Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers

Androgen-Repressed Phenotype in Human Prostate Cancer

Regions of Prostate-specific Antigen (PSA) Promoter Confer Androgen-independent Expression of PSA in Prostate Cancer Cells

A novel targeting modality to enhance adenoviral replication by vitamin D3 in androgen-independent human prostate cancer cells and tumors

Abstract 3109: Investigating the role of wild-type TFE3 in renal cell carcinoma cells harboring TFE3 fusions with spliceosome machinery associated genes

Tip110, the Human Immunodeficiency Virus Type 1 (HIV-1) Tat-interacting Protein of 110 kDa as a Negative Regulator of Androgen Receptor (AR) Transcriptional Activation

DEVELOPMENT OF PROSTATE-SPECIFIC ANTIGEN PROMOTER-BASED GENE THERAPY FOR ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER

The role of interleukin‐12 on modulating myeloid‐derived suppressor cells, increasing overall survival and reducing metastasis

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene

Suchergebnisse filtern